Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. - Wikidata - wikimedia - TriplyDB

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.

http://www.wikidata.org/entity/Q34522802

about

The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis Mining novel biomarkers for prognosis of gastric cancer with serum proteomics Prognostic value of preoperative serum tumor markers in gastric cancer.Identification of prognostic factors and surgical indications for metastatic gastric cancer.Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX.Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.Preoperative serum tumor marker levels in gastric cancer.Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.CA19-9-producing early gastric adenocarcinoma arising in hyperplastic foveolar polyp: a very unique resection case Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study Prognostic significance of tumor markers in T4a gastric cancer The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis).Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer Prognostic values of normal preoperative serum cancer markers for gastric cancer.Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls.Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.Peritoneal recurrence in gastric cancer following curative resection can be predicted by postoperative but not preoperative biomarkers: a single-institution study of 320 cases.Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer.Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.Preoperative globulin-to-albumin ratio predicts outcome after curative resection in patients with gastric cancer

P2860

Q21131782-D21620D0-88A0-4DCA-AF12-50A3C3AC0773 Q26748666-DEB274CB-5F93-42A5-96D8-4AE8CBD97E25 Q26828549-CB5C1A9B-3C72-4D9F-AAEB-2861973A9DC7 Q33501377-915E99DD-900A-4C3A-BA78-7F4A4113977A Q33585073-43D0C5C0-7F59-41FF-8D05-7B818ED99404 Q33755032-596ABD7E-BFEE-4A15-9B27-2A87BE8549AF Q33813676-D20806D5-3DFF-4259-A1D7-3E5CF59B7B91 Q33830752-8DDE8ED9-FF73-4CE1-9CAE-64500C262E1E Q34614931-981AF144-5A68-4578-A7FB-1AD23A2D065D Q34660420-2ABF95B8-3702-4164-BBF5-28AB8AFDE04F Q35560299-19557114-01DB-464E-B69E-F5727DAF93E6 Q35773128-25EF2325-77EA-4916-A2CC-17E1461F8DF9 Q35777594-409D47C9-0684-4AD1-AC15-2673ED7E7269 Q36125529-E990410D-8459-429A-80C6-C5F6B7FE5935 Q36191929-DBC2FE0E-EE5E-4E43-894B-11EBD7E0ECD5 Q36654661-F03BDBEF-93ED-4ACF-B2D1-5D7630737D82 Q36964966-0C903B10-8CF7-4166-8E29-A3B37385A8C6 Q37174708-D7DA71AD-1C49-46AD-A95A-328CBD37E9AA Q37386228-7E7A2B68-FBFA-4353-9569-5A97957DB611 Q37404845-BE995F83-04CA-471E-9822-DC9065CB8C1C Q37629042-17AF6781-5E95-46B6-AA7E-B89AD81AC591 Q37672230-9EEE0C26-C429-48C4-987B-252DF8BCB399 Q37735594-4961A241-C0C4-4657-912C-043D65758D7A Q38391277-8DB1A068-0D92-428D-907F-884B2509F46C Q39037474-A2CD632D-B01D-4C7E-9FEB-A9031768A55D Q39926759-93C7B71D-0859-427E-B555-2A5AB7564539 Q42878096-F2E68694-ED92-4923-893C-23E7C6B659B7 Q45893288-DE7ADD42-2B55-4CAF-AC74-C17205EAC712 Q47124055-0600D530-8777-490C-A0E6-AA524577C6C9 Q49645479-1C37B76B-51E6-4104-B722-818D58B70E42 Q50882005-84CAF16B-E420-47A5-88D5-F4A2B53359CE Q53130326-5FE79E6D-D8CA-422E-876B-6550D7597838 Q58779919-822290E1-E381-421E-A11C-C4154EE0A407

P2860

Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.

http://www.wikidata.org/entity/Q34522802

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@ast

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@en

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@nl

type

label

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@ast

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@en

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@nl

prefLabel

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@ast

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@en

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@nl

P1433

Q34522802-8BFDA56F-6B9F-4FC7-9B23-9D26A64D402C

P1476

Q34522802-E26EB460-2E82-473D-941B-D420878BF0E8

P2093

Q34522802-12F97591-9A21-4CB4-825D-DE8C8D0DBA74

Q34522802-2411E575-A2E3-4E26-B8EE-564BFC734CF2

Q34522802-30AEDF46-2A0B-494F-99DB-B9315B5C4AFC

Q34522802-356F9D78-463A-4EE6-B2C1-C3211C407D6C

Q34522802-65AD451A-A51B-45FF-BC37-8685C969FA28

Q34522802-7A0AC875-71F5-4F3D-A774-E23E5A281FC2

Q34522802-885BBCD3-CBCC-4248-A1A9-5C7206A6CE4D

Q34522802-915DA2D2-2B78-48E2-B907-1D205483DBFC

Q34522802-AFFC1F9D-A1EC-44CE-A3D6-0045EB77389E

Q34522802-C069BEAC-92A0-4F14-B3B5-C404211D9B7E

P2888

Q34522802-137ACBA8-7032-48EE-BF68-8DAD01750F17

P304

Q34522802-FCB11D6A-6AB0-4DCA-A281-D3CC77453BA3

P31

Q34522802-088FF700-24A7-412D-BCBE-C14769E4C8DE

P356

Q34522802-21836456-FE6E-453F-8B4F-172519B7EAEC

P433

Q34522802-DA6A5DE7-1926-4B39-B0F2-2C0275461F9B

P478

Q34522802-BAF21F7C-1A8D-43BC-996A-A91DD4C4D83F

P577

Q34522802-E986EF93-3A92-4478-BC25-A8574DA76F98

P5875

Q34522802-8CB6B416-AA93-4F29-B917-C45DF530DC9D

P6179

Q34522802-3570C14B-D15E-448C-AF1E-9E0B6983D521

P698

Q34522802-3AC18B7F-A166-4F8B-8EF9-3F3B27AAA9EA

P356

P1433

P1476

Evaluation of serum CEA and CA ...... patients with gastric cancer.

@en

P2093

Fumiro Mochizuki

http://www.w3.org/2001/XMLSchema#string

Kazuo Aizaki

http://www.w3.org/2001/XMLSchema#string

Masashi Fujii

http://www.w3.org/2001/XMLSchema#string

Mitsugu Kochi

http://www.w3.org/2001/XMLSchema#string

Mitsuko Kasahara

http://www.w3.org/2001/XMLSchema#string

Motoo Yamagata

http://www.w3.org/2001/XMLSchema#string

Noriaki Kanamori

http://www.w3.org/2001/XMLSchema#string

Teruo Kaiga

http://www.w3.org/2001/XMLSchema#string

Tetsuya Kawakami

http://www.w3.org/2001/XMLSchema#string

Yuichi Kasakura

http://www.w3.org/2001/XMLSchema#string

P2888

P304

177-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/PL00011715

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11384586

http://www.w3.org/2001/XMLSchema#string

P6179

1020317859

http://www.w3.org/2001/XMLSchema#string

P698

11984734

http://www.w3.org/2001/XMLSchema#string